Print
Health Care

New Lab In Wisconsin Expands Wilmington Based PPD's Testing Capabilities

By Jenny Callison, posted Mar 29, 2018
PPD this week announced a new analytical laboratory at its existing facility in Middleton, Wisconsin. The lab will expand PPD’s testing capacity, according to an announcement Wednesday by the Wilmington-based company.

The 32,000-square-foot Good Manufacturing Practices (GMP) lab “supplements the company’s existing biologics capacity and was constructed specifically for the stability and quality control testing of large molecule drug products,” the news release stated.

Planned for a workforce of more than 100, the new lab contains specialized areas designed for particular types of assays and scientific instrumentation specific to biologics, according to the release.

Biological products, or biologics, include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues and recombinant therapeutic proteins.

According to the Federal Drug Administration, biologics – as distinguished from chemical synthetics – are products isolated from a variety of natural sources. 

“The expansion of our biologics testing, which nearly doubles our analytical testing capacity, enables us to meet the ever-growing needs of our clients for GMP testing of large molecule products,” Jon Denissen, senior vice president of the PPD Laboratories bioanalytical and GMP labs, said in the release. “From early clinical development through commercial release testing, clients rely on our industry-leading capabilities in large molecule product testing. With deep expertise that spans the full spectrum of protein-based and gene-based biologics, we support many of the most cutting-edge immuno-oncology, gene therapy and cell therapy agents being developed or marketed today.”

PPD is also renovating its existing cell lab at the Middleton campus to double the lab’s capacity for GMP cell-based assays, the release stated, adding, “The expanded 5,900-square-foot laboratory will support a total of 70 cellular and molecular biology scientists upon its completion in mid-2018.”
Ico insights

INSIGHTS

SPONSORS' CONTENT
Mike stonestreet 300x300

Protecting Your Home from Floods

Mike Stonestreet - CAMS (Community Association Management Services)
Ch headshot

Beyond the Bench: UNC Wilmington Classroom to cGMP Laboratories

Hardy revised

Explore Careers in the Booming Field of Gerontology

Charles Hardy - UNCW College of Health and Human Services

Trending News

Sayed, Lee Join UNCW's Board Of Trustees

Johanna Cano - Jul 18, 2019

Halloween Likely To Film In Wilmington, Mayor Says

Cece Nunn and Christina Haley O'Neal - Jul 18, 2019

KWIPPED Receives $1.3M Investment

Johanna Cano - Jul 19, 2019

Realtors, Elected Officials Say Jobs, Affordable Housing Are Linked

Cece Nunn - Jul 18, 2019

Building UNCW's Future

Jenny Callison - Jul 19, 2019

In The Current Issue

Report: Airbnb, Hotels Don't Exactly Compete

While alternative lodging offered through Airbnb is gaining in popularity – and availability – travel officials say it’s not necessarily hur...


Building UNCW's Future

In his first year as chancellor of University of North Carolina Wilmington, Jose Sartarelli led the development of a fiveyear strategic plan...


More Zones, More Housing Options

For at least one potential apartment project, things might have been different if New Hanover County’s new zoning districts had already been...

Book On Business

The 2019 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!


Galleries

Videos

Power Breakfast - The H Word (June 13, 2019)
2019 WilmingtonBiz Expo Keynote Lunch - CEO, nCino, Pierre Naude`
Health Care Heroes 2018